FDA Approves Fexinidazole as the First All-Oral Treatment for Sleeping Sickness

Article Link: FDA Approves Fexinidazole as the First All-Oral Treatment for Sleeping Sickness

July 19, 2021 — The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei gambiense form of sleeping sickness (Human African trypanosomiasis) in patients 6 years of…

Source: FDA New Drug Approvals